4.8 Article

Pre-emptive Quality Control of a Misfolded Membrane Protein by Ribosome-Driven Effects

期刊

CURRENT BIOLOGY
卷 30, 期 5, 页码 854-+

出版社

CELL PRESS
DOI: 10.1016/j.cub.2019.12.060

关键词

-

资金

  1. US National Institutes of Health [R01 GM078186]
  2. UK Medical Research Council [MC_UP_1201/10, MC_U105161083]
  3. Boehringer Ingelheim Fonds
  4. Specialist Programme from Bloodwise [12048]
  5. Wellcome Trust [100140]
  6. MRC
  7. Conner Wright Project
  8. Cambridge National Institute for Health Research Biomedical Research Centre
  9. MRC [MC_UP_1201/10, MR/L003368/1, MC_U105161083, MC_PC_17230] Funding Source: UKRI

向作者/读者索取更多资源

Cells possess multiple mechanisms that protect against the accumulation of toxic aggregation-prone proteins. Here, we identify a pre-emptive pathway that reduces synthesis of membrane proteins that have failed to properly assemble in the endoplasmic reticulum (ER). We show that loss of the ER membrane complex (EMC) or mutation of the Sec61 translocon causes reduced synthesis of misfolded forms of the yeast ABC transporter Yor1. Synthesis defects are rescued by various ribosomal mutations, as well as by reducing cellular ribosome abundance. Genetic and biochemical evidence point to a ribosome-associated quality-control pathway triggered by ribosome collisions when membrane domain insertion and/or folding fails. In support of this model, translation initiation also contributes to synthesis defects, likely by modulating ribosome abundance on the message. Examination of translation efficiency across the yeast membrane proteome revealed that polytopic membrane proteins have relatively low ribosome abundance, providing evidence for translational tuning to balance protein synthesis and folding. We propose that by modulating translation rates of poorly folded proteins, cells can pre-emptively protect themselves from potentially toxic aberrant transmembrane proteins.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据